Oncode shows it can be done in a different way: an interview with Hans Clevers
Story
25 November 2021
Oncode shows it can be done in a different way: an interview with Hans Clevers
How can we as a society benefit even more from the knowledge that is being developed at our Dutch universities? How do you transfer this knowledge into innovations that boost our economy and offer solutions to our major societal challenges? These are some of the questions at the core of Oncode Institute. Oncode Investigator Hans Clevers, co-founder of Oncode Institute and professor Molecular Genetics at Utrecht University and UMC Utrecht answers them in this interview conducted by Teachleap.nl in collaboration with Innovation Origins.
Bianca-OliviaNita

<span>Bianca-Olivia</span><span>Nita</span>

Oncode Investigator Sylvie Noordermeer: ‘Setting up your own research group is both exciting ánd terrifying’
Story
25 November 2021
Oncode Investigator Sylvie Noordermeer: ‘Setting up your own research group is both exciting ánd terrifying’
Creating your own research group is exciting, but what are some of the typical challenges that can emerge? Oncode Investigator Sylvie Noordermeer (LUMC) discusses her experiences as founder of the Noordermeer research group, whilst also reflecting on the contribution that Oncode’s Mentoring Programme can make in solving dilemmas.
Marloesvan Amerom
Oncode-PACT proposal submitted to Growth Fund
News
17 November 2021
Oncode-PACT proposal submitted to Growth Fund
Oncode Institute is proud to announce that the Ministry of Economic Affairs and Climate Policy formally decided to submit the Oncode-PACT (Preclinical Accelerator for Cancer Treatments) proposal to the Growth Fund (Groeifonds) Commission on November 1st, 2021.
ElizeBrolsma

<span>Elize</span><span>Brolsma</span>

Elize is part of Oncode’s communication team. She has over 10 years of experience in the com-munication industry, both for commercial and non-profit organisations. After obtaining her bache-lor and master degree in communication at Utrecht University, Elize worked as a communication professional at a research institute, PR agency, law firm and internet company. She has a strong focus on external communications and Public Relations. At Oncode - together with her colleagues - Elize produces the monthly newsletters for Oncode Investigators & Researchers and the Oncode digital magazine. She publishes content for the Oncode website and is responsible for all social media channels. She enjoys discussing science with researchers and support them in their outreach.
Clinical trial with new lung cancer vaccine started
News
16 November 2021
Clinical trial with new lung cancer vaccine started
Last week a new clinical trial with a vaccine against non-small cell lung cancer started at Erasmus MC. The vaccine teaches the immune system of lung cancer patients to recognize and clear tumor cells. Developed in the lab of Oncode Investigator Sjoerd van der Burg at Leiden University Medical Center, the technology may offer relief to a large proportion of the nearly 10,000 patients who receive this diagnosis each year.
ElizeBrolsma

<span>Elize</span><span>Brolsma</span>

Elize is part of Oncode’s communication team. She has over 10 years of experience in the com-munication industry, both for commercial and non-profit organisations. After obtaining her bache-lor and master degree in communication at Utrecht University, Elize worked as a communication professional at a research institute, PR agency, law firm and internet company. She has a strong focus on external communications and Public Relations. At Oncode - together with her colleagues - Elize produces the monthly newsletters for Oncode Investigators & Researchers and the Oncode digital magazine. She publishes content for the Oncode website and is responsible for all social media channels. She enjoys discussing science with researchers and support them in their outreach.
A wrap-up of the Clinical Workshop Melanoma: looking into present approaches and what the future looks like
News
10 November 2021
A wrap-up of the Clinical Workshop Melanoma: looking into present approaches and what the future looks like
Due to restrictions linked to the pandemic, the Clinical Workshop Melanoma had to be postponed from last year to October this year. The restrictions relaxed and finally being able to come together, the long-expected event could take place. We now look back at a successful workshop that took place on the 5th of October at the Oncode office in Utrecht. The goal of the event was to bring together clinicians and clinical and basic researchers to discuss the tumor type melanoma, and to discuss current trends and unmet needs both within the clinic and in (clinical) research. The workshop aimed to also explore how basic research can address these unmet clinical needs and to stimulate new collaborations through translational and clinical projects.
Bianca-OliviaNita

<span>Bianca-Olivia</span><span>Nita</span>

Meet Oncode

Fundamental science, clinical testing and a sharp mind for market opportunities: at Oncode we bring it all together to create impact for patients.
https://www.oncode.nl/about/our-organisation
About
Our organization
Board, committees and an organigram. How we are organized and who does what: learn more about us.
https://www.oncode.nl/about/contact
About
How to contact us
We value your point of view. All you have to do is reach out and let us know if you have any questions, comments or suggestions.
https://www.oncode.nl/about/in-het-nederlands
About
In het Nederlands
Oncode is een internationale organisatie. Maar gezien onze oorsprong vertellen we ons verhaal ook graag in het Nederlands.
https://www.oncode.nl/about/partner-institutes-1
About
Our Partner Institutes
Universities, UMCs and research institutes: Oncode is proud to have twelve leading and well-respected Dutch institutes as its partners.